SAVIMS

Resource Type

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

VAERS Underreporting and Covid-19 Vaccine Harms

Reference: Edeling, H. J. (2022). The OpenVAERS Red Box Report. OpenVAERS. Retrieved from https://icandecide.org/v-safe-data/ Summary: The article highlights a study by Ross Lazarus and Michael Klompas, which revealed that the Vaccine Adverse Events Reporting System (VAERS) significantly underreports vaccine-related harms, estimating an underreporting factor (URF) of 10 to 100. Recent analyses following Covid-19 vaccinations have […]

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Analysis of Adverse Events Post-Vaccination

Reference: SAVAERS. (2022). Data for the period 09/02/2021 to 29/06/2022. Retrieved from www.SAVAERS.co.za Summary: The document presents data on adverse events reported following vaccination from 9 February 2021 to 29 June 2022. It details the timing of reported deaths relative to vaccination dates, categorising them by the number of days between injection and death. The

Covid-19 vaccines, Other scientific evidence, Resource Type, Treatment, Vaccine safety & adverse events, Vaccines

Vaccine Injury Treatment Guide Elizabeth Lee Vliet

Reference: Vliet, E. L. (2022). Vaccine injury treatment guide: Your road map to recovery. Truth for Health Foundation. Retrieved from www.TruthForHealth.org Summary: The “Vaccine Injury Treatment Guide” provides a comprehensive resource for individuals experiencing adverse effects from COVID-19 vaccines. Authored by Dr Elizabeth Lee Vliet and her team, it is based on peer-reviewed research and

COVID-19, Epidemiological surveillance, Other scientific evidence, Other viral illnesses, Resource Type, Statistical evidence, Viral illnesses

COVID-19 and Influenza Surveillance Insights (UKHSA – 2022)

Reference: UK Health Security Agency. (2022). Weekly national influenza and COVID-19 surveillance report: week 5 report (up to week 4 data). Summary: The UK Health Security Agency’s report for Week 5 of 2022 highlights a decrease in COVID-19 activity in England during Week 4, with reductions in case rates across various demographics. While positive rates

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Transmission Dynamics of SARS-CoV-2 Omicron Variant in Danish Households

Reference: Lyngse, F. P., Mortensen, L. H., Denwood, M. J., Christiansen, L. E., Møller, C. H., Skov, R. L., … & Krause, T. G. (2021). SARS-CoV-2 Omicron VOC transmission in Danish households. medRxiv. https://doi.org/10.1101/2021.12.27.21268278 Summary: This study investigates the transmission of the Omicron variant of SARS-CoV-2 within Danish households, comparing it to the Delta variant.

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

The Omicron Variant and the Vaccine Booster Debate

Reference: Khan, N. A., Al-Thani, H., & El-Menyar, A. (2022). The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues. Travel Medicine and Infectious Disease, 45, 102246. https://doi.org/10.1016/j.tmaid.2021.102246 Summary: The emergence of the Omicron variant of SARS-CoV-2 has sparked global concern due to its high mutation rate and potential

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccines, Viral illnesses

Impact of SARS-CoV-2 on the Brain and Vaccine Implications

Reference: Oldfield, P. R., Hibberd, J., & Bridle, B. W. (2022). How does severe acute respiratory syndrome-coronavirus-2 affect the brain and its implications for the vaccines currently in use. Vaccines, 10(1), 1. https://doi.org/10.3390/vaccines10010001 Summary: This article reviews how SARS-CoV-2 impacts the brain, particularly through its spike protein, which can cross the blood-brain barrier (BBB). Patients

COVID-19, Covid-19 vaccines, Other scientific evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Safety Analysis of Ad26.COV2.S Vaccine Among South African Healthcare Workers

Reference: Takuva, S., Takalani, A., Seocharan, I., Yende-Zuma, N., Reddy, T., Engelbrecht, I., Faesen, M., Khutlo, K., Whyte, C., Bailey, V., Trivella, V., Peter, J., Opie, J., Louw, V., Rowji, P., Jacobson, B., Groenewald, P., Dorrington, R. E., Laubscher, R., Bradshaw, D., Moultrie, H., Fairall, L., Sanne, I., Gail-Bekker, L., Gray, G., Gogar, A., Garrett,

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Treatment, Vaccine safety & adverse events, Vaccines, Viral illnesses

The Neurological Impact of SARS-CoV-2 and Vaccine Implications

Reference: Oldfield, P. R., Hibberd, J., & Bridle, B. W. (2022). How does severe acute respiratory syndrome-coronavirus-2 affect the brain and its implications for the vaccines currently in use. Vaccines, 10(1), 1. https://doi.org/10.3390/vaccines10010001 Summary: The article reviews how SARS-CoV-2 impacts the brain and discusses potential neurological complications tied to COVID-19 and vaccines. The spike protein

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Statistical evidence, Vaccines, Viral illnesses

Evaluating Covid-19 Vaccination Effects on Mortality in New Zealand

Reference: Hatchard, G. (2021, December 17). Relationship between Covid-19 vaccination and all cause mortality. Hatchard Report. https://hatchardreport.com/relationship-between-covid-19-vaccination-and-all-cause-mortality/ Summary: The article by Guy Hatchard investigates the correlation between mRNA Covid-19 vaccinations and all-cause mortality rates in New Zealand, particularly among individuals aged 60 and over. The analysis, facilitated by New Zealand’s unique border controls, allows for

Scroll to Top